Improving delivery of paclitaxel to ovarian cancer via expansile nanoparticles
Ended Cooperative Agreement Awarded Last action
- Award ID
- R43CA213538
- Recipient
-
Ionic Pharmaceuticals, LLC UEI K51MT3XNKME7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $283,122
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Place of performance
- Brookline, MA 02445, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $283,122 |
Quick answers
Who received award R43CA213538?
R43CA213538 was awarded to Ionic Pharmaceuticals, LLC by National Cancer Institute (National Institutes of Health) on March 15, 2017.
How much is award R43CA213538 worth?
$283,122 has been obligated on R43CA213538.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award